Scopio Labs Ltd.

Scopio Labs Ltd. develops Full-Field digital imaging and analysis platforms for clinical hematopathology, specifically targeting peripheral blood smear and bone marrow aspirate morphology assessment. The company manufactures high-resolution digital scanning devices and proprietary software that replaces traditional light microscopy with 100x dynamic full-field imaging, enabling remote viewing, collaboration, and standardized cell morphology analysis across laboratory networks. The platform includes AI-assisted decision support for autonomous cell differential counting and morphologic classification, addressing critical labor shortages and standardization challenges in hematology laboratories. Products include Peripheral Blood Smear Application (CE-marked, FDA-cleared for commercial use in US, UK, Europe, and other territories), Full-Field Bone Marrow Aspirate Application (CE-marked, cleared in select regions outside the US), and the upcoming Complete Blood Morphology (CBM) autonomous analysis system. The company partners with major hematology and pathology networks including Synnovis, Mount Sinai, PathGroup, Synlab, and others. Scopio's technology addresses rising testing volumes, critical staffing shortages, operator variability reduction, and enables 24/7 remote expert consultation without microscope dependency or on-site presence requirements.